Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response
Open Access
- 1 April 2003
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 9 (4) , 243-256
- https://doi.org/10.1053/bbmt.2003.50027
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- CD4+CD25+ Immunoregulatory T CellsThe Journal of Experimental Medicine, 2002
- Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow TransplantationThe Journal of Experimental Medicine, 2002
- Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease riskTransplantation and Cellular Therapy, 2002
- Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivoNature Immunology, 2001
- Regulatory T cells in spontaneous autoimmune encephalomyelitisImmunological Reviews, 2001
- Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: Correlations with epithelial tissue infiltrateTransplantation and Cellular Therapy, 2001
- A DECREASE IN GRAFT-VS.-HOST DISEASE WITHOUT LOSS OF GRAFT-VS.-LEUKEMIA REACTIVITY AFTER MHC-MATCHED BONE MARROW TRANSPLANTATION BY SELECTIVE DEPLETION OF DONOR NK CELLS IN VIVOTransplantation, 1992
- Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cellsNature, 1985
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979